chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vertigo started around the beginning of December, closing following an upper respiratory infection.   Also, the sinus pain I experienced during the upper respiratory infection didn?t go away (until the current day).  It has been aggravating my dysfunction and headache disorder.
Pt had herpatic appearing rash on leg where VARIVAX was given about 10 days following vaccination.
18 hours of fatigue. Soreness at sight of injection, nausea and headache
1 day following Covid booster, extreme exhaustion/fatigue, I had to lie down, unable to do normal daily activities. Day 2 following booster, fatigue worsened, had chills and night sweats. shortness of breath on exertion (going up stairs, walking from room to room). This level of fatigue lasted for about 5-6 days, then gradually improved. These symptoms were so unusual and concerning to me that I made an appointment with my PCP but was unable to see her until 10/31/22. At that time, I had begun to feel a bit better during the mornings, but by late afternoon, exhaustion and fatigue came back. As of today (11/2/22), my energy seems to be returning to normal levels, but I still feel weak, not as strong as I was before the booster.
Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product PANCREATIN capsule for Pancreatic insufficiency.    Concurrent medical conditions included Pancreatic necrosis, Non-smoker and Abstains from alcohol. Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), VITAMIN B COMPLEX and VITAMIN A [RETINOL] for an unknown indication.   In 2011, the patient PANCREATIN (Oral) dosage was changed to at an unspecified dose four times per day. In April 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In May 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and PANCREATIN (Oral) at an unspecified dose four times per day. In February 2022, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with SERUM DERIVED BOVINE IG/PROTEIN ISOLATE (ENTERAGAM) at a dose of Unknown, prn. On 03-Feb-2022, DIARRHOEA (Diarrhea) had resolved.            Patient had no known allergies.  Patient received third dose of Moderna vaccine on unknown date in Dec-2021 or Jan-2022.  The daily dose for Co-suspect Pancreatin was reported as 2 with each meal and 1 with snack. The patient had a full day of diarrhea on tuesday or wednesday in Feb-2022. She was taking Enteragam as needed and it stopped the diarrhea.  She was taking an unknown blood pressure medication.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   The reporter's causality for the event of diarrhoea with PANCREATIN was no reasonable possibility.   This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   This case was linked to MOD-2022-620234 (Patient Link).
Patient received vaccine here at Pharmacy.  A couple hours later, she felt a mild headache.  She then began having chills.  Later, she developed labored breathing.  She then laid in bed and began vomiting.  Her daughter then took her temperature.  It was 102 F.  She then went to the hospital.
Approximately 10 minutes after receiving  vaccine, patient exhibited altered mental status and confusion; eyes fixated upward and to the right for approximately 10-15 seconds.  Patient was placed on O2 and EMS called immediately; this practitioner called her name to reorient her and was successful.  She was able to answer simple questions at this time.  Vitals signs stable when EMS arrived.  Full assessment performed by EMS.  Patient's son notified.  He drove to office and drove her home.  She was then notified by our office upon returning home.
Development of Herpes Zoster lesions in C7 dermatome started several days ago.
Started with left neck under armpit pain. When the pain disappeared the itchy rash started around the injection shot of thr 3rd covid19 booster, went down the left arm, left chest, tummy. It has been wakimg me up at night. And now it is on my spine gluts, and back of both legs and ankles.
Fever for 2 days,  chest pain for 2 days, swelling and tenderness underarm still ongoing today,  fuzzy mouth and dry chapped lips still today 4 days after dose, red swollen warm at injection site still at 4 days after vaccine.
child devel redness, warmth, swelling & tenderness @ vax site w/in 24hr of vax;sx c/w cellulitis;
I had no adverse effects at first, just a slight sore arm.  A couple of days after receiving the second dose, I started with heart palpitations, skipped beats, pounding and stopping at night when I laid down and after eating dinner.  I have no history of any heart conditions, problems of any sort.
patient gets sick from the shot; Initial information was regarding an unsolicited valid non-serious case received from a consumer or non-health care professional via social media and transmitted to Sanofi on 11-Nov-2020.   This case involves a male patient (unknown age) who got sick (Illness), after the patient received vaccine INFLUENZA VACCINE (flu shot).  The patient's medical history, past medical treatment(s), concomitant therapy, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, (Unknown latency) the patient got sick from the shot (illness) after getting the INFLUENZA VACCINE (flu shot).  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the outcome was unknown for the reported event.  There will be no information available on the batch number for this case.
Headache right after vaccine was administered.  Approximately 40min after vaccine was administered I had severe dry mouth, inability to swallow, at about an hour after vaccine was administered my lips tongue and throat were swelling.  Diarrhea, chills, dizziness, severe tremors.
I ALWAYS got the flu after a flu vaccine; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 04-Dec-2020.  This case involves a patient of unknown demographics who reportedly always got the flu (influenza) after receiving Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the patient reported suffering from flu and got the flu (influenza) unknown period after the administration of influenza vaccine.  It was not reported if the patient received a corrective treatment.  Outcome of the event was not resolving, at the time of reporting.  There will be no information available on the batch number for this case.
injuries resulting from Zostavax use: Shingles; Shingles; products liability - defective design; manufacturing defect; Information has been received from a lawyer regarding a case in litigation concerning a currently 74 years old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  The patient was prescribed the Zoster Vaccine Live (ZOSTAVAX) vaccine by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. In 2010, the patient was administered zoster vaccine live(ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) by a pharmacist. On an unknown date, the patient was treated by a healthcare provider for the following injuries resulting from the patient's Zoster Vaccine Live (ZOSTAVAX) use: shingles.  The patient claimed damages as a result of: Injury to themselves; Loss of consortium; Loss of services; Economic losses.  The following claims were asserted: negligence; products liability - defective design; products liability - manufacturing defect; products liability-failure to warn; breach of express warranty; breach of implied warranty; fraudulent misrepresentation; fraudulent concealment; negligent misrepresentation; unjust enrichment; strict liability; consumer fraud; loss of consortium; punitive damages.  The outcome of the events was unknown. Causality assessments were related.
covid test date=21Aug2021, covid test result=Positive/Body aches, lost of smell and taste; covid test date=21Aug2021, covid test result=Positive/Body aches, lost of smell and taste; Body aches; Lost of smell and taste; Lost of smell and taste; This is a spontaneous report from a contactable other health care professional (patient). A 39-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: FA7485), via an unspecified route of administration, administered in arm left on 29Jul2021 at 12:30 PM (at the age of 39 years) as DOSE 1, SINGLE and second dose of bnt162b2 (Batch/Lot Number: FC3182) via an unspecified route of administration, administered in arm left on 19Aug2021 at 08:30 AM (at the age of 39 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Vaccine was administered at pharmacy or drug store. No other vaccines were received within four weeks prior to the administration of bnt162b2. Medical history included asthma, neurofibromatosis and penicillin allergy; all from an unknown date and unknown if ongoing. Concomitant medication included montelukast sodium (SINGULAIR) taken within two weeks of vaccination for an unspecified indication, start and stop date were not reported. On 30Jul2021 at 07:30 AM, the patient experienced body aches, lost of smell and taste. The report was non serious (as reported). On 21Jul2021, the patient underwent covid test post vaccination at hospital with covid test type nasal swab: negative, on 31Jul2021, covid test post vaccination as Binaxnow test with covid test type nasal swab: negative, on 21Aug2021, covid test post vaccination as Binaxnow test with covid test type nasal swab: positive. Events were considered as medically significant. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was tested for COVID-19. No treatment was received for the adverse events. Outcome of the events was not recovered.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported event Covid 19 and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
1-2 minutes after vaccine was administered infant became cyanotic  and limp, O2 via bag started. Infant recovered no further treatment administered. Discharged home 1 1/2 hours after vaccine in good health.
Had bruising since late October which continued to get worse. It was Nov 15 that my tongue turned purple and I went to the hospital for diagnosis and found out my platelets were at 7,000.
Hives on left and right forearms and chest. Took benadryl. It started approximately 18 hours after my vaccination on my left forearm. Approximately 24 hours after the vaccination it started on my chest and then the right forearm and continued on the left forearm
Started to feel itchy next day followed by swollen around eyes/ cheeks and upper face.  History of dermal fillers in the face.  Inflammatory response limited to face.
Information has been received from a healthcare worker concerning a 17 year old female with concomitant medications, allergies, and pertinent medical history reported as none, who on 13-NOV-2007 was vaccinated with the first dose of GARDASIL.  A second dose of GARDASIL (Lot # 659657/1487U), 0.5ml, IM was given on an unspecified date.  The patient is experiencing hair loss, reportedly starting "two weeks ago" (01-MAY-2008).  The patient sought medical attention over the telephone.  No outcome information was reported.  No product quality complaint was involved.  Additional information has been requested.
A few minutes after administration the patient went to leave the room where he got his vaccine. He stood up turned to ask another question about the vaccine and then fainted. He was out for about 15 seconds. He awoke disoriented and sweaty. I gave him water and some glucose tablets. He said he felt fine after that.  i have called to follow with him and he says he fells fine
EYESIGHT DETERIORATED; LEGS WERE IMMOBILE; BLOOD PRESSURE WAS SKY HIGH; MANY OTHER SIDE EFFECTS; This spontaneous report received from a patient concerned a 26 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: The patient was healthy and never had any type of illness or hospitalization before getting the vaccine. The patient received covid-19 vaccine ad26.cov2.s (dose series 1, suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported, 1 total, administered for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced eyesight deteriorated, legs were immobile, blood pressure was sky high, and many other side effects. After receiving vaccine last spring and one week later patient was hospitalized. The patient had a number of different side effects which she believes was from the vaccine and none of which patient had before the vaccine. After more than a week got discharged from hospital. It was an awful event for patient and her family. Number of days hospitalized was not reported.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the eyesight deteriorated, legs were immobile, blood pressure was sky high and many other side effects was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20211236040-Covid-19 vaccine ad26.cov2.s - Eyesight deteriorated, legs were immobile, blood pressure was sky high ,many other side effects. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
Hives from neck down to elbow on left side.  Wet cough, chest pain over sternum and on left side llq on coughing.  Fatigue, arm pain, localized swelling/inflammation.
Information has been received from a pharmacist regarding to a male patient of unknown age. The patient's medical history included out breaks of shingles. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose, route, and lot number were not provided). No other co-suspects were reported. Concomitant medications included: azathioprine. The pharmacist stated that recently in giving a patient a flu shot he inquired about the option of getting a second ZOSTAVAX vaccination. He stated that when he received his first vaccination he was on azathioprine where it was noted the immune response to vaccinations might be decreased. Since his vaccination he noted he had shingles once and while it was not the most visible of his out breaks it was his most painful. Patient's outcome was unknown. Additional information has been requested.
My left arm from first vaccine has not been the same since; muscle weakness and pain. My chiropractor believes as the dosage was given a little lower that my lymphatic drainage did not happen the way it should have. This last Saturday she did ultrasound treatment, massage, and taped up my arm. This has not resolved my symptoms. Not sure what to do at this point.  My right arm from second vaccine is fine.
Fatigue; arm soreness; Myalgia; Fever; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), PAIN IN EXTREMITY (arm soreness), MYALGIA (Myalgia) and PYREXIA (Fever) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (Fatigue), PAIN IN EXTREMITY (arm soreness), MYALGIA (Myalgia) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE (Fatigue), PAIN IN EXTREMITY (arm soreness), MYALGIA (Myalgia) and PYREXIA (Fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: high (High) 101.3 degrees..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not provided.
Slight head pressure within 5 minutes of injection Headache, left arm soreness, small rash at injection site, chills, fever, hot flashes, and muscle pain occurring throughout the day after injection. Sore arm and swollen and sore left armpit lymph nodes, continued headache, soreness throughout body.
Patient received shot on 12/23/08 at 9:30am (left arm), he had swelling and heat at injection site the morning of 12/25/08. On 12/26/08 (in the morning) developed swelling in left hand, and injection site was red and really swollen. By 6pm on 12/26/08 the hand was normal, site  still pink and swollenness has decreased slowly recovering.
This spontaneous report as received from a 56 year old male patient with recurrent respiratory papilloma (RRPP) refers to himself. The patient had no pertinent medical history and drug reactions or allergies. About a year ago, in June 2013, the patient was vaccinated with GARDASIL (dose, number, dose, frequency, route and lot number not reported). The patient completed the 3 dose series of doctor's office, actual dates unspecified. There were no concomitant medications. The patient ws outside age indication for GARDASIL as he had a condition called recurrent respiratory papilloma (RRPP). The patient stated: "RRPP is the same virus, HPV, but affects vocal cords, requires periodic surgeries." The patient discussed taking GARDASIL with physicians in order to prevent reoccurrence and minimize need for surgery. The patient stated that ever since he took GARDASIL, condition had not flared up. The patient had seen specialist doctor twice, the doctor checked patient's condition periodically with certain instruments to take pictures of vocal cords and there was not much growth. The patient stated he was doing fine now and would see the doctor again over the summer for follow up evaluation. Additional information has been requested,
Patient called on 8/21/2017 and reported that he had pain in his arm, forearm and middle of his hand of the arm he got the flu shot in. No numbness, fever or rash. He said it has gotten progressively worse since he had the shot. CDC call suggested he see his MD to get the site checked out, we advised that to the patient.
This spontaneous report as received from a registered nurse refers to a 12 years old patient. The nurse reported that the patient was intended to receive VARIVAX was inadvertently administered ZOSTAVAX subcutaneous on 13-AUG-2012. No treatment information was reported. No adverse effects reported. It was unspecified if the patient had sought medical attention. Additional information has been requested.
Area at the site of injection is is worm; Arm pain since two weeks; Redness and swelling is 1 inch long and 1 inch. wide.; Redness and swelling is 1 inch long and 1 inch. wide; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide). At the time of the report, VACCINATION SITE WARMTH (Area at the site of injection is is worm), VACCINATION SITE PAIN (Arm pain since two weeks), VACCINATION SITE ERYTHEMA (Redness and swelling is 1 inch long and 1 inch. wide.) and VACCINATION SITE SWELLING (Redness and swelling is 1 inch long and 1 inch. wide) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: events outcome updated.
Client received the J& J Covid vaccine injection at the Health clinic and within 40-60 seconds had c/o "feeling funny" and felt like he was going to pass out. Client started to have a seizure-like activity, and loss consciousness two times. Ice packs and cooling clothes were applied to clients forehead and neck after client seizure-like activity stopped, feet elevated. Client was diaphoretic, gray, started twitching (which he said is normal when he gets nervous.) BP was low at 86/64. EMT called and client evaluated. Client refused transport to hospital. Client recovered from episode after an hour and left with his wife from the health department able to walk and communicate on his own.
Body aches; No appetite; Feeling unsteady/dizzy; Fever (100.8° after taking Tylenol); This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), DECREASED APPETITE (No appetite), DIZZINESS (Feeling unsteady/dizzy) and PYREXIA (Fever (100.8° after taking Tylenol)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038K20A and 038K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal and Cholesterol high. Concomitant products included OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]).   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced PAIN (Body aches), DECREASED APPETITE (No appetite), DIZZINESS (Feeling unsteady/dizzy) and PYREXIA (Fever (100.8° after taking Tylenol)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of unknown. At the time of the report, PAIN (Body aches), DECREASED APPETITE (No appetite), DIZZINESS (Feeling unsteady/dizzy) and PYREXIA (Fever (100.8° after taking Tylenol)) had not resolved.            patient uses unspecified blood pressure and cholesterol medications as concomitants.